In hard gelatin capsule filling of Qingre Jiedu Powder veterinary API, the as-received powder is first conditioned through a 0.8 mm coni-sieve before loading into an automatic capsule filler. The powder typically shows a bulk density of 0.35–0.55 g/cm³ and a tapped density of 0.50–0.75 g/cm³, producing a Hausner ratio above 1.25 and limiting direct gravity flow from hopper to dosator. On a Zanasi Z-5000 continuous dosator machine, bridging is observed when powder bed depth exceeds 300 mm, requiring paddle agitation at 30–60 rpm. Dosator nozzle diameter is set at 8–14 mm for target fill masses of 300–700 mg. Lubricant blending with 0.5–1.0 wt% magnesium stearate in a bin blender at 15 rpm for 3–5 min is used to reduce sticking; over-lubrication above 1.5 wt% increases dissolution variability beyond RSD 10% under USP <2040> testing. Moisture is controlled to ≤5.0% by loss-on-drying; above 6.0% hygroscopic agglomerates bind to dosator pins and fill weight variation exceeds ±5%. Content uniformity follows USP <905> with an acceptance value not greater than 15.0. Capsule shells are selected as size 0 or 1 veterinary gelatin or HPMC capsules; HPMC shells at RH 45–55% avoid crosslinking with aldehydic degradation products from the botanical extract. If storage humidity exceeds 60% RH, slugging or roller compaction is required before encapsulation.

Why Do Botanical Extract Powders Fall Outside Direct Compression Envelopes on Rotary Tablet Presses?

Direct compression of Qingre Jiedu Powder veterinary API on a Korsch XL 100 rotary press is limited by the low plasticity index and high elastic recovery of dried botanical matrices. Tablets compressed at 8–12 kN frequently cap within 4–6 hours of ejection when external lubrication is below 0.3 wt%. The failure is magnified at turret speeds above 40 rpm because insufficient dwell time under pressure prevents interparticulate bonding of amorphous polysaccharide domains. A wet granulation route with 5–10 wt% povidone K30 binder solution in 50% v/v ethanol is used; granulation endpoint is determined by impeller power consumption on a high-shear mixer, with binder addition over 3–5 min and wet massing time of 2–4 min. The granulate is dried in a fluid-bed dryer at inlet air temperature 55–65°C to final moisture of 2.0–4.0%. Dried granules are sized through a 1.0 mm screen and blended with 1.0 wt% crospovidone and 0.5 wt% magnesium stearate. Compression force on the rotary press is maintained at 10–16 kN with pre-compression at 3–5 kN; tablet hardness ranges from 5–8 kp for 12 mm round flat-faced bevel tooling. Friability remains below 1.0% per USP <1216> only when granulate moisture is above 2.5%. Processing above 4.0% moisture causes sticking to the upper punch face and filming of the lower punch after 60–90 min continuous run. In-line NIR moisture monitoring on the tablet press feed frame detects batch drift above 5.0% and diverts the blend. The formulation boundary is specific: alkaline lubricants such as sodium stearyl fumarate should be avoided if the extract contains tannin-polyphenols because surface darkening and disintegration delays beyond 30 min in USP <701> apparatus may occur.

Terminal Sterilization and Particulate Control in Aqueous Veterinary Injections

At pH 5.5–6.5, Qingre Jiedu Powder veterinary API is dispersed in Water for Injection at 40–50°C, followed by clarification through 0.45 µm and 0.22 µm polyethersulfone membrane filters. The sterile filtrate is filled into Type I glass vials under ISO 14644-1 Class 5 conditions. Particulate matter in final vials must satisfy USP <788>: not more than 6000 particles ≥ 10 µm and 600 particles ≥ 25 µm per container for volumes ≤ 100 mL. The botanical extract loads polysaccharides and polyphenolic colloids that foul the membrane within 10–20 L/m²; prefiltration with activated carbon at 0.1–0.5 wt% and a 1.0 µm depth filter extends throughput to 50–80 L/m². Terminal steam sterilization at 121°C for 15 min is constrained by degradation of flavonoid markers; aseptic filtration is preferred when the extract contains heat-labile components, and bioburden before sterilization must be below 10 CFU/100 mL. Endotoxin control is achieved by 10 kDa ultrafiltration; the final specification is ≤0.5 EU/mL for intravenous administration in cattle and swine. Multi-dose vials require benzyl alcohol at 1.0–2.0% v/v; benzyl alcohol is incompatible with polysorbate 80 above 5.0% due to phase separation. Precipitation of polyphenol-protein complexes occurs below pH 4.0, while oxidation of phenolic acids accelerates above pH 8.0. For intramuscular administration in cattle, final osmolality is adjusted to 280–320 mOsm/kg with sodium chloride or glycerol. Vial headspace is flushed with nitrogen when dissolved oxygen exceeds 1.0 mg/L. Published stability data for this specific multi-component veterinary API under terminal steam sterilization are limited; the above processing boundary is derived from thermolabile flavonoid behavior in botanical parenterals.

For open drinking water systems in poultry houses, oral solutions of Qingre Jiedu Powder veterinary API are prepared at 1–5 g/L active concentration. The water-insoluble extraction residue, ranging from 15–30% w/w depending on the botanical source, is removed by centrifugation or 200 mesh screening before the solution reaches nipple drinkers. If the product is packaged as a soluble powder for drinking water, a carrier blend of dextrose monohydrate and sodium citrate at 1:1 w/w ratio is dry-mixed to improve wetting; the blend passes through an 80 mesh sieve to ≥95%. Hard water with total hardness above 300 mg/L CaCO₃ produces precipitates with polyphenolic acids within 60–120 min; EDTA disodium at 0.05–0.20% w/v is required. The pH of medicated water is adjusted to 5.0–6.0 because alkaline pH above 7.5 accelerates oxidation and reduces marker compounds. In a 1000 L header tank, dissolution is optimized with a high-shear mixer at 1500–3000 rpm for 10–15 min; without mechanical dispersion, floating agglomerates block in-line filters. Microbiological quality follows USP <1231> guidance for pharmaceutical waters; total aerobic microbial count is maintained below 100 CFU/mL in the diluted drinking water. Solutions are consumed within 24 h because the dissolved extract supports microbial growth; if storage beyond 48 h is required, 0.1% w/v sodium benzoate is added as a preservative.

When Qingre Jiedu Powder Is Dispersed Into Feed Premixes Under Low-Shear Mixing

In feed premix manufacturing, the API is incorporated at 10–100 g/kg active concentration into a carrier such as ground corn cob, rice hulls, or calcium carbonate. Particle size mismatch between the API cut point of ≤150 µm and the carrier cut point of 400–800 µm creates segregation during auger transfer; the problem is controlled by stepwise geometric dilution and by matching bulk densities within 0.15 g/cm³. Ribbon blender fill level is maintained at 40–70% of working capacity with mixing time of 10–20 min at 20–30 rpm. Coefficient of variation for 10 stratified samples is held at ≤5.0%; higher values indicate dead zones near the ribbon shaft end plates. The premix is then diluted to a final feed concentration of 1–10 kg per tonne for swine and poultry. Carryover prevention follows 21 CFR 225.165; flush material does not contain more than 1.0% of the previous batch active. Moisture in the premix is controlled below 12.0% because higher values cause caking during storage. Antioxidants such as BHT at 100–200 ppm may be required if the premix is stored for more than 30 days at 25°C and 60% RH. The process is incompatible with steam conditioning above 85°C during subsequent pelleting because thermal degradation of polyphenolic markers exceeds 10%.

Fluidized-bed top spray granulation of Qingre Jiedu Powder veterinary API is conducted with a Wurster column or standard top-spray granulator. The API is pre-mixed with microcrystalline cellulose and lactose monohydrate in a ratio of 30:40:30 w/w. The binder solution, 5% w/v povidone K30 or hydroxypropyl cellulose, is sprayed at 20–50 g/min with atomizing air pressure of 1.5–2.5 bar. Inlet air temperature is set at 50–60°C; product bed temperature is kept at 35–40°C. Granulation end point is reached when moisture content approaches 4–5%, as measured by a continuous capacitance probe. Final granules are dried to ≤3.0% moisture and sieved through 20–60 mesh. The granules are used for sachets or as an intermediate for tablet compression. The process is constrained by the glass transition of amorphous botanical sugars: if product temperature exceeds 60°C, the bed defluidizes due to interparticle liquid bridges; if the spray rate exceeds 60 g/min, agglomerates above 2.0 mm form and plug the outlet. Residual solvent testing follows USP <467> when 50% v/v ethanol is used as binder solvent; ethanol is below 500 ppm in the final granulate.

Granulation Routes Do Not Scale Linearly From 10 kg to 300 kg

Scaling from 10 kg pilot-scale granulation to 300 kg production batches of Qingre Jiedu Powder veterinary API changes droplet distribution and bed hydrodynamics. At 10 kg, a spray rate of 20–50 g/min produces a normalized spray flux of 0.5–1.0; at 300 kg, the same top-spray nozzle setting can create local overwetting because the bed surface area to spray footprint ratio decreases. Transfer to a 300 kg Glatt GPCG 300 requires atomization air pressure adjustment to 2.0–3.0 bar and lower spray rate normalized to 0.25–0.50 g/min/kg dry mass. Product temperature is held below 60°C to avoid glass transition-induced defluidization; this is measured by a 10-point IR array and controlled by inlet air dew point below 5°C. Scale-up failure modes include top-spray nozzle bearding and filter bag moisture saturation, which reduce exhaust flow after 45–60 min and raise bed humidity above 70% RH. In-line near-infrared moisture analysis at the bottom discharge port terminates drying at 2.5–3.5% moisture. Published data for this specific multi-component veterinary extract under 300 kg scale transfer are limited; the above processing boundary is extrapolated from fluid-bed granulation of hygroscopic botanical extracts.